Optimising Pharmaceutical Products Using Formulation Science, Tablets & Capsules
By PatheonBy Kwok Chow, PhD, and Mark J Kontny, PhD
Approval of new drug products that treat unmet medical needs held steady or declined over the last decade.
Meanwhile, pharma companies continue to consolidate, R&D budgets continue to decline, and the cost of conducting late-stage clinical trials continues to escalate.
This article summarises techniques for formulating poorly water-soluble APIs and how selecting the right outsourcing partner can accelerate development.
Download to read more.